Cytomegalovirus (CMV) infection occurs very often after solid organ transplantation and is often a life-threatening complication of long-term immunosoppressive therapy. Actually it is unknown which type of drug is indicated to control the infection in immunocompromised patients. We studied 10 consecutive patients who had undergone heart-transplantation and in which CMV infection was the commonest post-transplant infectious disease. Our results suggest a careful monitoring of IgG seropositivity in heart transplant patients, especially when it is not possible to know the serum status of the donor.
VancikovaZ.DvorakP.2001. Cytomegalovirus infection in immunocompetent and immunocompromised individuals–review. Curr. Drug Targets Immune Endocr. Metabol. Disord.1:179.
2.
SlifkinM.TempestiP.PoutsiakaD.D.SnydmanD.R.2001. Late and atypical cytomegalovirus disease in solid-organ transplant recipients. Clin. Infect. Dis.33:62.
3.
FalagasM.E.SnydmanD.R.1995. Recurrent cytomegalovirus disease in solid-organ transplant recipients. Transpl. Proc.27:34.
4.
IbererF.TscheliessniggK.HalwachsG.RehakP.PetutschniggB.SchreierG.MullerH.AllmayerH.FreigassnerM.PrennerG.HipmairG.GrasserB.1996. Definitions of cytomegalovirus disease after heart transplantation: Antigenemia as a marker for antiviral therapy. Transpl. Int.9:236.
5.
CamargoL.F.UipD.E.SimpsonA.A.CaballeroO.StolfN.A.Vilas-BoasL.S.PannutiC.S.2001. Comparison between antigenemia and a quantitative-competitive polymerase chain reaction for the diagnosis of cytomegalovirus infection after heart transplantation. Transplantation71:412.
6.
AveryR.K.1998. Prevention and treatment of cytomegalovirus infection and disease in heart transplant recipients. Curr. Opin. Cardiol.13:122.
7.
RubinR.H.2000. Prevention and treatment of cytomegalovirus disease in heart transplant patients. J. Heart Lung Transplant19:731.
8.
IsadaC.M.Yen-LiebermanB.KohnD.2000. Emergence of clinically significant ganciclovir (GCV)-resistant strains of CMV in solid organ transpalnt recipients. Transplantation69:181.
9.
AntretterH.HoferD.KlausA.LarcherC.MargreiterJ.MargreiterR.2000. Cytomegalovirus infection after heart transplantation. Retrospective analysis of an antiviral CMV prevention. Dtsch. Med. Wochenschr.125:445.
10.
EspositoS.RenzulliA.AgozzinoL.ThomopoulosK.PiccoloM.MaielloC.Della CorteA.CotrufoM.1999. Late complications of heart transplantation: An 11-year experience. Heart Vessels14:272.
11.
NicodL.P.1996. Infectious complications of lung and heart-lung transplantation. Rev. Mal. Respir.13:41.
12.
KunzleN.PetignatC.FrancioliP.VogelG.SeydouxC.CorpatauxJ.M.SahliR.MeylanP.R.2000. Preemptive treatment approach to cytomegalovirus (CMV) infection in solid organ transplant patients: Relationship between compliance with the guidelines and prevention of CMV morbidity. Transpl. Infect. Dis.2:118.
